Clinical Drug Experience Knowledgebase

diazoxide (hyperstat) (1 trial)

Insulin, bovine (1 trial)

insulin human (humulin) (12 trials)

sotagliflozin (Inpefa) (4 trials)

aflibercept (zaltrap) (1 trial)

allopurinol (zyloprim) (2 trials)

anakinra (Kineret) (1 trial)

atorvastatin (lipitor) (1 trial)

dapagliflozin (farxiga) (2 trials)

faricimab (Vabysmo) (1 trial)

fenofibrate (fenoglide) (1 trial)

insulin aspart (Novolog) (4 trials)

insulin lispro (humalog) (3 trials)

liraglutide (victoza) (3 trials)

nicotinamide (1 trial)

otelixizumab (3 trials)

pramlintide (symlin) (6 trials)

quinapril (accupril) (1 trial)

ramipril (altace) (1 trial)

sirolimus (rapamune) (3 trials)

sitagliptin (januvia) (6 trials)

sodium chloride (4 trials)

ustekinumab (stelara) (2 trials)

abatacept (orencia) (6 trials)

acetazolamide (diamox) (1 trial)

alagebrium (1 trial)

aldesleukin (Proleukin) (3 trials)

alefacept (Amevive) (1 trial)

alemtuzumab (campath) (2 trials)

allogeneic pancreatic islet cells (9 trials)

alpha-1 antitrypsin (Prolastin) (2 trials)

aluminum hydroxide (Gaviscon) (1 trial)

ambrisentan (letairis) (1 trial)

Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (4 trials)

autologous umbilical cord blood (2 trials)

baricitinib (olumiant) (1 trial)

belatacept (nujolix) (2 trials)

bone marrow derived mesenchymal stem cells (1 trial)

bromocriptine (parlodel) (1 trial)

colchicine (colbenemid) (1 trial)

cyclosporine (sandimmune) (1 trial)

daclizumab (Zenapax) (1 trial)

diamyd (1 trial)

dl-2-(difluoromethyl) ornithine (1 trial)

doxycycline (vibramycin) (2 trials)

efalizumab (Raptiva) (4 trials)

everolimus (zortress) (1 trial)

gad-alum (2 trials)

gevokizumab (1 trial)

glucagon (4 trials)

hydroxychloroquine (plaquenil) (1 trial)

ico-007 (1 trial)

imatinib (gleevec) (1 trial)

infliximab (remicade) (1 trial)

insulin glulisine (Apidra) (1 trial)

Lactobacillus johnsonii N6.2 (2 trials)

lansoprazole (prevacid) (1 trial)

mecamylamine (inversine) (1 trial)

methylprednisolone (medrol) (1 trial)

mycophenolate (CellCept) (1 trial)

pantoprazole (protonix) (1 trial)

prednisone (meticorten) (1 trial)

proinsulin human (1 trial)

ranibizumab (lucentis) (4 trials)

remd-477 (1 trial)

rituximab (rituxan) (2 trials)

sargramostim (leukine) (1 trial)

sb-509 (2 trials)

semaglutide (Ozempic) (2 trials)

simvastatin (zocor) (1 trial)

teplizumab (Tzield) (4 trials)

ttp399 (1 trial)

Ursodoxicoltaurine (1 trial)

verapamil (calan) (2 trials)

cepolytreg (1 trial)

ex vivo expanded human autologous polyclonal regulatory t cells (1 trial)

Filgrastim (neupogen) (1 trial)

golimumab (simponi) (1 trial)

icosapent ethyl (vascepa) (2 trials)

kvd001 (1 trial)

leptin (1 trial)

maltodextrin (1 trial)

piperidic acid (1 trial)

autologous microbiome (1 trial)

beta carotene (solatene) (1 trial)

fatty acid (1 trial)

gamma-amino-beta-hydroxybutyric acid (1 trial)

glimepiride (amaryl) (1 trial)

l-cysteine (cysteine hydrochloride) (1 trial)

medium chain triglyceride (1 trial)

methyldopa (aldomet) (1 trial)

selenium (1 trial)

vitamin c (1 trial)

vitamin d3 (1 trial)

vitamin e (1 trial)

zinc (1 trial)